Ligand validation:3P50

PLC: DIUNDECYL PHOSPHATIDYL CHOLINE

PLC is a Ligand Of Interest in 3P50 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3P50_PLC_D_321	4%	7%	0.353	0.806	1.63	3.11	4	12	1	0	67%	0.6667
3P50_PLC_C_320	2%	9%	0.433	0.784	1.48	2.98	5	11	1	0	67%	0.6667
3P50_PLC_E_320	1%	8%	0.452	0.728	1.53	2.99	4	11	1	0	67%	0.6667
3P50_PLC_B_320	1%	7%	0.467	0.701	1.62	3.08	4	11	2	0	67%	0.6667
3P50_PLC_A_320	1%	8%	0.548	0.722	1.51	3.04	5	11	1	0	67%	0.6667
3P50_PLC_E_321	1%	71%	0.613	0.834	0.57	0.54	-	-	0	0	21%	0.2143
3P50_PLC_C_321	0%	65%	0.72	0.868	0.64	0.69	-	-	0	0	21%	0.2143
3P50_PLC_B_321	0%	69%	0.647	0.758	0.67	0.54	-	-	1	0	21%	0.2143
3P50_PLC_A_321	0%	67%	0.721	0.75	0.71	0.55	-	-	1	0	21%	0.2143
3P50_PLC_D_322	0%	68%	0.963	0.502	0.52	0.71	-	-	0	0	21%	0.2143
3UUB_PLC_F_320	16%	88%	0.19	0.908	0.45	0.22	-	-	0	0	17%	16.669999999999998
6HZ1_PLC_E_401	12%	95%	0.233	0.842	0.19	0.2	-	-	0	0	57%	0.5714
4QH5_PLC_E_403	10%	47%	0.272	0.806	1.1	0.94	2	2	0	0	81%	0.8095
6HZW_PLC_D_403	9%	11%	0.221	0.742	1.83	2.37	3	9	0	0	81%	0.8095
6HYW_PLC_D_401	8%	68%	0.272	0.783	0.48	0.74	-	1	0	0	81%	0.8095
4DOS_PLC_A_603	64%	52%	0.134	0.933	0.97	0.88	2	-	1	0	100%	0.869
4P00_PLC_A_922	12%	42%	0.283	0.836	1.12	1.12	2	3	1	0	90%	0.9048
4P02_PLC_B_802	10%	82%	0.251	0.892	0.26	0.54	-	-	0	0	26%	0.2619
5EJZ_PLC_B_803	10%	72%	0.261	0.91	0.3	0.77	-	-	1	0	21%	0.2143

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.